Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal-Reference-Cited by-同舟云学术

Cost-effectiveness of influenza vaccination with a high dose quadrivalent vaccine of the elderly population in Belgium, Finland, and Portugal

Published:2023-05-23 Issue:1 Volume:26 Page:710-719
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Alvarez Fabián P.¹^ORCID,Chevalier Pierre²,Borms Matthias²,Bricout Hélène¹^ORCID,Marques Catia³,Soininen Anu⁴,Sainio Tatu⁵,Petit Christine⁶,de Courville Caroline¹^ORCID

Affiliation:

1. Sanofi, Lyon, France

2. IQVIA, Zaventem, Belgium

3. Sanofi, Porto Salvo, Portugal

4. Sanofi, Espoo, Finland

5. Medaffcon Oy, Espoo, Finland

6. Sanofi, Diegem, Belgium

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2023.2194193

Reference61 articles.

1. John Hopkins University. Conditions and diseases → influenza [cited 2023 Mar 13]. Available from: https://www.hopkinsmedicine.org/health/conditions-and-diseases/influenza

2. The disease burden of influenza beyond respiratory illness

3. The role of influenza in the epidemiology of pneumonia

4. Acute myocardial infarction after laboratory-confirmed influenza infection;Kwong JC;N Engl J Med,2018

5. Influenza-like illness as a trigger for ischemic stroke

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of recombinant influenza vaccine compared with standard dose influenza vaccine in adults 18–64 years of age;Vaccine;2024-10

2. New Vaccines for Chronic Respiratory Patients;Archivos de Bronconeumología;2024-09

3. Public health and economic benefits of seasonal influenza vaccination in risk groups in France, Italy, Spain and the UK: state of play and perspectives;BMC Public Health;2024-05-03

4. Cost-effectiveness of high-dose influenza vaccination in the Netherlands: Incorporating the impact on both respiratory and cardiovascular hospitalizations;Vaccine;2024-05

5. High‐Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults;Influenza and Other Respiratory Viruses;2024-04